-+ 0.00%
-+ 0.00%
-+ 0.00%

AGENUS REPORTS MORE THAN HALF OF PATIENTS WITH REFRACTORY MSS METASTATIC COLORECTAL CANCER ACHIEVED LONG-TERM SURVIVAL FOLLOWING BOT+BAL TREATMENT AT SITC 2026

Reuters·11/06/2026 14:00:01

Please log in to view news